Pharma giant Novo Nordisk is investing more in Ireland hoping to capitalize on the obesity-drug boom https://t.co/XcHe48qkw7 ...

Novo hired a new US chief charged with turning around the company’s most important market where mounting pricing pressure and intensifying competition are eroding its grip on the obesity-drug boom https://t.co/PTyHGpL1Te ...